Design, Synthesis and Cytotoxicity of Novel Chalcone Analogs Derived from 1-Cyclohexylpyrrolidin-2-one and 2,3-Dihydrobenzo[f]chromen-1-one

被引:8
作者
Brien, Kimberly A. [1 ,2 ]
Bandi, Ravi Kumar [3 ]
Behera, Ajaya Kumar [3 ]
Mishra, Bijay Kumar [3 ]
Majumdar, Poulomi [3 ]
Satam, Vijay [1 ,2 ]
Savagian, Mia [1 ,2 ]
Tzou, Samuel [1 ,2 ]
Lee, Megan [1 ,2 ]
Zeller, Matthias [4 ]
Robles, Andrew J. [5 ]
Mooberry, Susan [5 ,6 ]
Pati, Hari [3 ]
Lee, Moses [1 ,2 ]
机构
[1] Hope Coll, Div Nat Sci, Holland, MI 49423 USA
[2] Hope Coll, Dept Chem, Holland, MI 49423 USA
[3] Sambalpur Univ, Dept Chem, Sambalpur, Orissa, India
[4] Youngstown State Univ, Dept Chem, Youngstown, OH 44555 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[6] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
关键词
Benzochromanone; Chalcones; Cytotoxicity; Tubulin; X-ray; SUBSTITUTED CHALCONES; ANTINEOPLASTIC AGENTS; DERIVATIVES; 2-ARYLIDENEBENZOCYCLOALKANONES; COMBRETASTATIN-A4; INHIBITORS; GROWTH; POTENT; CELLS; A-4;
D O I
10.1002/ardp.201100265
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two divergent series of novel chalcone analogs, one derived from 1-cyclohexylpyrrolidin-2-one and the other derived from 1-benzo[f]chromanone, were designed, synthesized and evaluated for cytotoxicity against two murine cancer cell lines. Two 1-benzo[f]chromanone analogs, 4g and 4j yielded moderate toxicity against both melanoma B16 and lymphoma L1210 cell lines with IC50 values between the range of 5 and 6?mu M. With an IC50 value of 3.4?mu M, compound 4g was also active against human MDA-MB-435 melanoma cells. X-ray structures of the beta-hydroxy ketone product (4a) and the a,beta-unsaturated ketone (4h) were collected, and confirm the syn-configuration between the carbonyl moiety and the beta-vinylic proton in 4h. X-ray structures of two 1-cyclohexylpyrrolidin-2-one derivatives were also obtained, and both showed an E-configuration for the double bond.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 29 条
[1]  
[Anonymous], APEX2 V2009 7 0
[2]  
[Anonymous], 2000, SHELXTL VERS 6 14
[3]   Acetyl analogs of combretastatin A-4: Synthesis and biological studies [J].
Babu, Balaji ;
Lee, Megan ;
Lee, Lauren ;
Strobel, Raymond ;
Brockway, Olivia ;
Nickols, Alexis ;
Sjoholm, Robert ;
Tzou, Samuel ;
Chavda, Sameer ;
Desta, Dereje ;
Fraley, Gregory ;
Siegfried, Adam ;
Pennington, William ;
Hartley, Rachel M. ;
Westbrook, Cara ;
Mooberry, Susan L. ;
Kiakos, Konstantinos ;
Hartley, John A. ;
Lee, Moses .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (07) :2359-2367
[4]   Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: Synthesis, biological evaluation, molecular modeling and structure-activity relationship (SAR) [J].
Bello, Murilo Lamim ;
Chiaradia, Louise Domeneghini ;
Sousa Dias, Luiza Rosaria ;
Pacheco, Leticia Kramer ;
Stumpf, Taisa Regina ;
Mascarello, Alessandra ;
Steindel, Mario ;
Yunes, Rosendo Augusto ;
Castro, Helena Carla ;
Nunes, Ricardo Jose ;
Rodrigues, Carlos Rangel .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (16) :5046-5052
[5]   On the Synthesis and Anticancer Testing of α,β-Unsaturated Ketones as Analogs of Combretastatin-A4 [J].
Chavda, Sameer ;
Davis, Ryan ;
Ferguson, Amanda ;
Riddering, Camille ;
Dittenhafer, Kristin ;
Mackay, Hilary ;
Babu, Balaji ;
Lee, Moses ;
Siegfried, Adam ;
Pennington, William ;
Shadfan, Miriam ;
Mooberry, Susan L. ;
Mishra, Bijay K. ;
Pati, Hari N. .
LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (07) :531-537
[6]   Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography [J].
Dimmock, JR ;
Zello, GA ;
Oloo, EO ;
Quail, JW ;
Kraatz, HB ;
Perjési, P ;
Aradi, F ;
Takács-Novák, K ;
Allen, TM ;
Santos, CL ;
Balzarini, J ;
De Clercq, E ;
Stables, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) :3103-3111
[7]   Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones [J].
Dimmock, JR ;
Kandepu, NM ;
Nazarali, AJ ;
Kowalchuk, TP ;
Motaganahalli, N ;
Quail, JW ;
Mykytiuk, PA ;
Audette, GF ;
Prasad, L ;
Perjési, P ;
Allen, TM ;
Santos, CL ;
Szydlowski, J ;
De Clercq, E ;
Balzarini, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) :1358-1366
[8]   Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly [J].
Ducki, S ;
Mackenzie, G ;
Lawrence, NJ ;
Snyder, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) :457-465
[9]   Potent antimitotic and cell growth inhibitory properties of substituted chalcones [J].
Ducki, S ;
Forrest, R ;
Hadfield, JA ;
Kendall, A ;
Lawrence, NJ ;
McGown, AT ;
Rennison, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (09) :1051-1056
[10]   CHALCONES - A NEW CLASS OF ANTIMITOTIC AGENTS [J].
EDWARDS, ML ;
STEMERICK, DM ;
SUNKARA, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) :1948-1954